TAF1B Antibody (OTI1A8) [Biotin]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-74441B
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Western Blot
Label
Biotin
Antibody Source
Monoclonal Mouse IgG1 Clone # OTI1A8
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Recombinant protein fragment corresponding to amino acids 1-208 of human TAF1B (NP_005671) produced in E.coli.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1
Applications for TAF1B Antibody (OTI1A8) [Biotin]
Application
Recommended Usage
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: TAF1B
Alternate Names
RAF1BTATA box binding protein (TBP)-associated factor, RNA polymerase I, B, 63kD, RAFI63MGC:9349, RNA polymerase I-specific TBP-associated factor 63 kDa, SL1SL1, 63kD subunit, TAFI63TBP-associated factor 1B, TATA box binding protein (TBP)-associated factor, RNA polymerase I, B, 63kDa, TATA box-binding protein-associated factor 1B, TATA box-binding protein-associated factor RNA polymerase I subunit B, Transcription initiation factor SL1/TIF-IB subunit B
Gene Symbol
TAF1B
Additional TAF1B Products
Product Documents for TAF1B Antibody (OTI1A8) [Biotin]
Product Specific Notices for TAF1B Antibody (OTI1A8) [Biotin]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...